People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RESTOR3D, Inc. | — | Other Health Care | Series C | $239.2M | $522.0M | 2022 |
| Vata7, Inc. | — | Other Technology | Pre-Seed | $981K | $7.3M | 2021 |
Brian Garvey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Garvey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Adams | 1 | 14 |
| Andrew Miller | 1 | 8 |
| Kurt Jacobus | 1 | 5 |
| Kenneth Gall | 1 | 5 |
| Douglas Kohrs | 1 | 4 |
| Ken Gall | 1 | 4 |
| ANDREW SUMMERS | 1 | 3 |
| Michael Porter | 1 | 3 |
| JAMES STUBBS | 1 | 3 |
| Ken Pedersen | 1 | 2 |
| Jeff Hatcher | 1 | 2 |
| William Rhoda | 1 | 2 |
| Cambre Kelly | 1 | 2 |
| Ken Todd Gall | 1 | 1 |
| Andrew Todd Miller | 1 | 1 |
| Jim Sherrington | 1 | 1 |
| Lisa Schutz | 1 | 1 |
| Greg Anglum | 1 | 1 |
| Erich E. Wolff | 1 | 1 |
| Brian Neiswender | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.